See More

European stocks dip on debt worries

Dec 17 2010 14:11 Reuters

Related Articles

US stocks open mixed; inflation data

European shares rise, EU meeting eyed

Asian stocks sluggish after Wall St gains

Asian stocks rise on Chinese growth

US stocks rise after retail sales boost

Global stocks, oil up on China


London - European shares slipped on Friday, with investors cautious as concerns grew about the eurozone peripheral debt crisis, while AstraZeneca's dropped as a key drug failed to win US approval.

By 09:57 am, the pan-European FTSEurofirst 300 index of top shares was 0.1% lower at 1 129.98 points after rising 0.4% in the previous session.

"There is still ongoing work to be done on the European Union crisis mechanism, I think once you start looking at the details, that is when the difficulties start to come in," Jeremy Batstone-Carr, head of equities at Charles Stanley, said.

"Investors want to know about the size of it, what the terms are and who will contribute."

European Union leaders have agreed to create a permanent financial safety net from 2013 and the European Central Bank said it would nearly double its capital to €10.76bn to cope with bigger credit risk.

Batstone-Carr also said to be wary about reading into what is going on in the market because there is triple witching, when contracts for stock index futures, stock index options and stock options all expire at the same time.

"I think a lot of investors would prefer to get out rather than get involved right now," he added.

Banks, which have been hard hit by the eurozone sovereign debt crisis, were under pressure after Moody's Investors Service slashed Ireland's credit rating by five notches to Baa1 from Aa2.

Bank of Ireland slumped 6.7%, while Barclays, Credit Agricole and Lloyds Banking Group fell 0.7% to 1.1%.

On Thursday the ratings agency also put Greece's credit rating on review for a possible downgrade. Drugmakers also featured among the worst performers, with the STOXX Europe 600 Health Care down 1%. AstraZeneca fell 5% after its new heart medicine Brilinta failed to win approval from US regulators.

Techs gain

On the upside, technology stocks were in demand. SAP gained 1.4% after traders pointed to forecast-beating results of peer Oracle and Qatar's finance minister said the emirate did not rule out investing in the German software giant.

Autonomy jumped 4.3%, also boosted by Oracle's results.

Nokia gained 1% after the quarterly profit of its smaller rival, No. 4 cellphone maker Research In Motion, beat analyst expectations.

"RIM's fiscal 3Q11 shipments confirm expectations of robust smartphone demand at the end of 2010, particularly as it doesn't include the high volume final weeks in December," CCS Insight analyst Geoff Blaber said.

Across Europe, the FTSE 100 index was 0.3% higher, Germany's DAX gained 0.1% and France's CAC 40 was 0.4% higher.

The Peripheral Eurozone Countries Index was 0.9% higher.



Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Add your comment
Comment 0 characters remaining

Company Snapshot

We're talking about:


Johannesburg has been selected to host the Global Entrepreneurship Congress in 2017. "[The congress] will ensure that small business development remains firmly on the national agenda and the radar screen of all stakeholders, the Small Business Development minister said.

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

People who fall victim to Ponzi scams are:

Previous results · Suggest a vote